Medicinal cannabis improves sleep in adults with insomnia: a randomised double‐blind placebo‐controlled crossover study
Journal of Sleep Research · 2023-06 · 32 (3)
DOI: 10.1111/jsr.13793 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Sleep Research, online erschienen am 20.12.2022. Verfasst von Karin Ried und 3 weiteren Autor:innen. Beteiligte Einrichtung: National Institute of Integrative Medicine (NIIM), Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Sleep Initiation and Maintenance Disorders, Medical Marijuana, Melatonin. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Schlaf
Abstract (Originalsprache)
Insomnia or difficulty falling and or staying asleep is experienced by up to 30% of the general population. This randomised crossover double‐blind placebo‐controlled 6‐week trial aimed to assess the tolerability and effectiveness of the Entoura‐10:15 medicinal cannabis oil on sleep in adults with insomnia. A total of 29 participants with self‐reported clinical insomnia completed the crossover trial. Participants were randomly allocated to receive placebo or active oil containing 10 mg/ml tetrahydrocannabinol (THC) and 15 mg/ml cannabidiol (CBD) over 2‐weeks titrated 0.2–1.5 ml/day, followed by a 1‐week wash‐out period before crossover. Tolerability was assessed by daily diary. Effectiveness was measured by saliva midnight melatonin levels, validated questionnaires, i.e., the Insomnia Severity Index, and the Fitbit activity/sleep wrist tracker. Entoura‐10:15 medicinal cannabis oil was generally well tolerated, and was effective in improving sleep, whereby 60% of participants no longer classified as clinical insomniacs at the end of the 2‐week intervention period. Midnight melatonin levels significantly improved in the active group by 30% compared to a 20% decline in the placebo group ( p = 0.035). Medicinal cannabis oil improved both time and quality of sleep, in particular light sleep increased by 21 min/night compared to placebo ( p = 0.041). The quality of sleep improved overall by up to 80% in the active group ( p Phase2 = 0.003), including higher daily functioning ( p = 0.032). Observed effects were more pronounced in Phase 2 due to the period effect and loss of blinding. Entoura‐10:15 medicinal cannabis oil was well tolerated and effective in improving sleep in adults with insomnia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Institute of Integrative Medicine (NIIM), Melbourne, Victoria, Australia.
- Torrens University, Adelaide, South Australia, Australia.
- Discipline of General Practice, The University of Adelaide, Adelaide, South Australia, Australia.
ORCID-Profile: Karin Ried
Zitieren
APA
Ried, K., Tamanna, T., Matthews, S., & Sali, A. (2023). Medicinal cannabis improves sleep in adults with insomnia: a randomised double‐blind placebo‐controlled crossover study. Journal of Sleep Research, 32(3). https://doi.org/10.1111/jsr.13793
Vancouver
Ried K, Tamanna T, Matthews S, Sali A. Medicinal cannabis improves sleep in adults with insomnia: a randomised double‐blind placebo‐controlled crossover study. Journal of Sleep Research. 2023;32(3). doi:10.1111/jsr.13793
BibTeX
@article{Ried2023,
author = {Ried, Karin and Tamanna, Tasnuva and Matthews, Sonja and Sali, Avni},
title = {Medicinal cannabis improves sleep in adults with insomnia: a randomised double‐blind placebo‐controlled crossover study},
journal = {Journal of Sleep Research},
year = {2023},
volume = {32},
number = {3},
doi = {10.1111/jsr.13793}
}
EUVIMED